Biostem Technologies Inc
OTC:BSEM

Watchlist Manager
Biostem Technologies Inc Logo
Biostem Technologies Inc
OTC:BSEM
Watchlist
Price: 17.41 USD -25.47% Market Closed
Market Cap: 284.5m USD
Have any thoughts about
Biostem Technologies Inc?
Write Note

Biostem Technologies Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biostem Technologies Inc
Accounts Payable Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Biostem Technologies Inc
OTC:BSEM
Accounts Payable
$1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Accounts Payable
$9B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Accounts Payable
$3.5B
CAGR 3-Years
9%
CAGR 5-Years
13%
CAGR 10-Years
3%
Pfizer Inc
NYSE:PFE
Accounts Payable
$5.1B
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
6%
Merck & Co Inc
NYSE:MRK
Accounts Payable
$3.6B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
5%
Eli Lilly and Co
NYSE:LLY
Accounts Payable
$2.9B
CAGR 3-Years
23%
CAGR 5-Years
21%
CAGR 10-Years
11%

See Also

What is Biostem Technologies Inc's Accounts Payable?
Accounts Payable
1m USD

Based on the financial report for Dec 31, 2023, Biostem Technologies Inc's Accounts Payable amounts to 1m USD.

What is Biostem Technologies Inc's Accounts Payable growth rate?
Accounts Payable CAGR 1Y
27%

Over the last year, the Accounts Payable growth was 27%.

Back to Top